NCT01735370View on ClinicalTrials.gov

Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Fasting
Interventions
DRUG

Etodolac Tablets USP 500mg

500 mg tablet once a day

DRUG

Etodolac Tablets USP 500 mg

500 mg tablet once a day

Trial Locations (1)

Unknown

Veeda Clinical Research Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY